Status:
COMPLETED
A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Brief Summary
This survey is conducted in South America. The aim of this survey is to investigate hypoglycaemia among Insulin-treated patients with diabetes.
Eligibility Criteria
Inclusion
- Informed consent obtained before any study-related activities
- The following patients will be considered eligible for inclusion in the study: Patients with T1DM (Type 1 Diabetes Mellitus) or T2DM (Type 2 Diabetes Mellitus) treated with insulin for more than 12 months and patients at least 18 years of age at the time of the survey
Exclusion
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Illiterate patients and patients otherwise unable to complete a written survey
- Non-ambulatory patients
- Simultaneous participation in any other clinical study with an investigational product
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
704 Patients enrolled
Trial Details
Trial ID
NCT02230631
Start Date
October 1 2014
End Date
March 1 2015
Last Update
April 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Säo Paulo, Brazil, 05001-400